HSP105 antigen peptide dendritic cell vaccine (Medinet)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameHSP105 antigen peptide dendritic cell vaccine (Medinet)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapyVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionHeat shock protein HSP105 modulators

TargetsHeat shock protein HSP105

Therapy Area/IndicationsPancreatic NeoplasmsColorectal NeoplasmsEsophageal Neoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsYes

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedinet

China Registration ClassN/A

Develop Information

Active CompaniesMedinet

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsColorectal NeoplasmsEsophageal Neoplasms +[4]

Inactive IndicationsN/A

Other Information

ATC CodeN/A